Padsevonil randomized Phase IIa trial in treatment-resistant focal epilepsy: a translational approach

P. Muglia, J. Hannestad, C. Brandt, S. DeBruyn, M. Germani, B. Lacroix, M. Majoie, C. Otoul, D. Sciberras, B.J. Steinhoff, K. Van Laere, W. Van Paesschen, E. Webster, R.M. Kaminski, K.J. Werhahn, M. Toledo

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number183
Number of pages15
JournalBrain Communications
Volume2
Issue number2
DOIs
Publication statusPublished - 1 Jan 2020

Keywords

  • [c-11]ucb-j
  • animal-models
  • antiepileptic drug
  • benzodiazepines
  • brivaracetam
  • drug discovery
  • drug-resistant epilepsy
  • efficacy
  • human brain
  • imaging
  • occupancy
  • partial-onset seizures
  • pet
  • pharmacoresistant epilepsy
  • refractory epilepsy
  • seizures
  • HUMAN BRAIN
  • REFRACTORY EPILEPSY
  • EFFICACY
  • DRUG DISCOVERY
  • BRIVARACETAM
  • OCCUPANCY
  • [C-11]UCB-J
  • ANIMAL-MODELS
  • PHARMACORESISTANT EPILEPSY
  • BENZODIAZEPINES
  • SEIZURES
  • PET

Cite this